Failure of prostacyclin analog iloprost to sustain coronary blood flow after recombinant tissue-type plasminogen-induced thrombolysis in dogs
- 31 August 1993
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 126 (2) , 285-292
- https://doi.org/10.1016/0002-8703(93)91041-c
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosisCardiovascular Research, 1991
- Guidelines for the early management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1990
- Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis.Circulation, 1990
- Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator.Circulation, 1989
- Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarctionJournal of the American College of Cardiology, 1989
- Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.Circulation, 1989
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- Insights into the pathogenesis of acute ischemic syndromes.Circulation, 1988
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Augmentation of Streptokinase-Induced Thrombolysis by Heparin and ProstacyclinJournal of Cardiovascular Pharmacology, 1985